Atai Life Sciences Total Liabilities 2020-2024 | ATAI
Atai Life Sciences total liabilities from 2020 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Atai Life Sciences Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $49 |
| 2022 | $40 |
| 2021 | $28 |
| 2020 | $16 |
| 2019 | $2 |
| Atai Life Sciences Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $51 |
| 2024-06-30 | $47 |
| 2024-03-31 | $46 |
| 2023-12-31 | $49 |
| 2023-09-30 | $40 |
| 2023-06-30 | $38 |
| 2023-03-31 | $40 |
| 2022-12-31 | $40 |
| 2022-09-30 | $47 |
| 2022-06-30 | $29 |
| 2022-03-31 | $29 |
| 2021-12-31 | $28 |
| 2021-09-30 | $21 |
| 2021-06-30 | $21 |
| 2021-03-31 | $25 |
| 2020-12-31 | $16 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.268B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.257B | 0.00 |
| Quest Diagnostics (DGX) | United States | $16.849B | 17.08 |
| DaVita (DVA) | United States | $12.285B | 15.89 |
| Encompass Health (EHC) | United States | $9.254B | 21.82 |
| Chemed (CHE) | United States | $7.946B | 24.42 |
| Elanco Animal Health (ELAN) | United States | $5.957B | 14.18 |
| RadNet (RDNT) | United States | $5.193B | 115.00 |
| Option Care Health (OPCH) | United States | $3.863B | 18.31 |
| Amedisys (AMED) | United States | $2.977B | 21.19 |
| LifeStance Health (LFST) | United States | $2.889B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.253B | 26.44 |
| Astrana Health (ASTH) | United States | $1.811B | 24.77 |
| U.S Physical Therapy (USPH) | United States | $1.327B | 34.87 |
| Pennant (PNTG) | United States | $0.909B | 36.75 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.871B | 0.00 |
| Bioqual (BIOQ) | United States | $0.058B | 0.00 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.003B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |